NJ State Employees Deferred Compensation Plan’s Kindred Biosciences, Inc. KIN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-32,000
| Closed | -$293K | – | 515 |
|
|
2021
Q2 | $293K | Hold |
32,000
| – | – | 0.04% | 423 |
|
|
2021
Q1 | $159K | Hold |
32,000
| – | – | 0.02% | 494 |
|
|
2020
Q4 | $138K | Hold |
32,000
| – | – | 0.02% | 475 |
|
|
2020
Q3 | $137K | Hold |
32,000
| – | – | 0.02% | 442 |
|
|
2020
Q2 | $144K | Hold |
32,000
| – | – | 0.03% | 441 |
|
|
2020
Q1 | $128K | Hold |
32,000
| – | – | 0.03% | 416 |
|
|
2019
Q4 | $271K | Hold |
32,000
| – | – | 0.05% | 429 |
|
|
2019
Q3 | $219K | Hold |
32,000
| – | – | 0.04% | 459 |
|
|
2019
Q2 | $267K | Hold |
32,000
| – | – | 0.05% | 462 |
|
|
2019
Q1 | $293K | Buy |
32,000
+9,000
| +39% | +$82.4K | 0.05% | 437 |
|
|
2018
Q4 | $252K | Hold |
23,000
| – | – | 0.05% | 414 |
|
|
2018
Q3 | $321K | Sell |
23,000
-17,000
| -43% | -$237K | 0.05% | 421 |
|
|
2018
Q2 | $426K | Sell |
40,000
-10,000
| -20% | -$107K | 0.08% | 358 |
|
|
2018
Q1 | $433K | Hold |
50,000
| – | – | 0.08% | 338 |
|
|
2017
Q4 | $473K | Buy |
+50,000
| New | +$473K | 0.08% | 341 |
|